Influenza vaccines: Antibody responses to split virus and MF59- adjuvanted subunit virus in an adult population

European Journal of Epidemiology

Volumn 15, Issue 6, 1999, Pages 573-576

  Menegon, T ^a   Baldo, Vincenzo ^a   Bonello, C ^b   Dalla Costa, D ^b   Di Tommaso, A ^b   Trivello, R ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b Public Health Department   (Italy)

Author keywords

Adjuvant; Immune response; Influenza; Vaccination

Indexed keywords

INFLUENZA VACCINE;

ADULT; AGED; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HEMAGGLUTINATION INHIBITION TEST; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; VIRUS STRAIN; WINTER;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODY FORMATION; DOUBLE-BLIND METHOD; FEMALE; HEMAGGLUTINATION TESTS; HUMANS; INFLUENZA VACCINES; LOGISTIC MODELS; MALE; MIDDLE AGED;

EID: 0032804298     PISSN: 03932990     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007594911541     Document Type: Article

References (23)

1. Couch RB, Kasel JA, Glezen WP, Cate TR, Six HR, Taber CH. Influenza: Its control in persons and populations. J Infect Dis 1986; 153: 431-440.
2. Kohn RP. Cause of death in very old people. JAMA 1982; 247: 2793-2797.
3. Centers for Disease Control. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1997; 46: 1-25.
4. Bradley SF. Influenza in the elderly. Prevention is the best strategy in high-risk populations. Postgraduate Medicine 1996; 99: 138-149.
5. Beyer WEP, Palache AM, Baljet M, Masurel N. Antibody induction by influenza vaccines in the elderly: A review of the literature. Vaccine 1989; 7: 385-394.
6. McElhaney JE, Meneilly GS, Lechelt KE, Beattie BL, Bleackley RC. Antibody response to whole-virus and split-virus influenza vaccines in successful ageing. Vaccine 1993; 11: 1055-1060.
7. Glathe H, Siegwart B, Grosche A. Comparison of humoral immune responses to trivalent influenza split vaccine in young, middle-aged and elderly people. Vaccine 1993; 11: 702-705.
8. Beyer WEP, Palache AM, Sprenger MJW, et al. Effects of repeated annual influenza vaccination on vaccine sero-response in young and elderly adults. Vaccine 1996; 14: 1331-1339.
9. Gross PA, Denning CR, Gaerlan PF, et al. Annual influenza vaccination: Immune response in patients over 10 years. Vaccine 1996; 14: 1280-1284.
10. Pozzilli P, Gale EAM, Visalli N, et al. The immune response to influenza immunisation in diabetic patients. Diabetologica 1986; 29: 850-854.
11. Gupta RK, Relyveld EH, Lindblad EB, Bizzini B, BenEfraim S, Gupta CK. Adjuvants - a balance between toxicity and adjuvanticity. Vaccine 1993; 11: 293-306.
12. Martin JT. Development of an adjuvant to enhance the immune response to influenza vaccine in the elderly. Biologicals 1997; 25: 209-213.
13. Minutello M, Senatore F, Cecchinelli G, et al. Safety and immunogenicity of an inactivated subunit influenza virus combined with MF59 adjuvant emulsion in elderly subjects, immunized for three consecutive influenza seasons. Vaccine 1999; 17: 99-104.
14. Ott G, Barchfeld GL, Chernoff D, Radhakrishnan R, van Hoogevest P, Van Nest G. MF59: Design and evaluation of a safe and potent adjuvant for human vaccines. In: Powell MF, Newman MJ (eds), Vaccine design: The subunit approach. New York: Plenum Press, 1995: 277-296.
15. Eikhoff TC, Sherman IL, Serfling RE. Observations on excess mortality associated with epidemic influenza. JAMA 1961; 176: 776-782.
16. Foster DA, Talsma A, Furumoto-Dawson A, et al. Influenza vaccine effectiveness in preventing hospitalization for pneumonia in the elderly. Am J Epidemiol 1992; 136: 269-307.
17. Govaert TME, Sprenger MJW, Dinant GJ, Aretz K, Masurel N, Knottnerus JA. Immune response to influenza vaccination of elderly people. A randomized double-blind placebo-controlled trial. Vaccine 1994; 12: 1185-1189.
18. Nichol KL, Margolis KL, Wuorenma J, et al. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med 1994; 331: 778-784.
19. Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowski RA. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med 1995; 123: 518-527.
20. Hobson D, Baker FA, Curry RL. Effect of influenza vaccines in stimulating antibody in volunteers with prior immunity. Lancet 1973; 155-156.
21. McElhaney JE, Meneilly GS, Lechelt KE, Bleackley RC. Split-virus influenza vaccines: Do they provide adequate immunity in the elderly? J Gerontol Med Sci 1994; 49: 37-43.
22. Strassburg MA, Greenland S, Sornvillo FJ, et al. Influenza in the elderly: Report of an outbreak and a review of vaccine effectiveness reports. Vaccine 1986; 4: 38-44.
23. Powers DC. Influenza vaccination strategies for the elderly. Aging Immunol Infect Dis 1994; 5: 47-54.